Functional Assays for Pneumococcal Antibody

作者: Moon H. Nahm , Sandra Romero-Steiner

DOI: 10.1128/9781555815820.CH15

关键词:

摘要: This chapter reviews opsonophagocytosis assay (OPA) methods for pneumococcal antibodies and the experience with OPA in clinical trials, stressing need further standardization of OPA. In case conjugate vaccines (PCV), studies suggest that vaccine-induced primarily help phagocytes ingest kill pneumococci. mechanism host protection is described this chapter. Given essential defense against pneumococci, are designed to induce opsonic antibodies. The describes two different types clinically available various laboratory measures were used estimate their protective efficacy. PCV becomes T cell dependent, induces B-cell memory, can elicit anti-polysaccharide (PS) young children. most desirable surrogate measuring immunity. uses a historical approach describe methods. However, classical very tedious perform, due counting colonies. Consequently, many researchers have developed alternative requiring no colony counting, including radiolabeled-bacterium uptake assay, fluorescent-bacterium chemiluminescence, an oxidative-burst generation assay. Clinical measured opsonophagocytic antibody activity children adults. Due past methodological difficulties, these tended be small size. They nevertheless informative thus discusses Finally, finally talks about future activities will likely become basis evaluating efficacy protein vaccines.

参考文章(78)
Lynda M. Stuart, R. Alan B. Ezekowitz, Phagocytosis: Elegant Complexity Immunity. ,vol. 22, pp. 539- 550 ,(2005) , 10.1016/J.IMMUNI.2005.05.002
Joseph E. Prince, Cory F. Brayton, Milligan C. Fossett, Jennifer A. Durand, Sheldon L. Kaplan, C. Wayne Smith, Christie M. Ballantyne, The Differential Roles of LFA-1 and Mac-1 in Host Defense Against Systemic Infection with Streptococcus pneumoniae The Journal of Immunology. ,vol. 166, pp. 7362- 7369 ,(2001) , 10.4049/JIMMUNOL.166.12.7362
Hattie D. Gresham, Jon H. Lowrance, Tony E. Caver, Bridget S. Wilson, Ambrose L. Cheung, Frederik P. Lindberg, Survival ofStaphylococcus aureusInside Neutrophils Contributes to Infection The Journal of Immunology. ,vol. 164, pp. 3713- 3722 ,(2000) , 10.4049/JIMMUNOL.164.7.3713
Donald N. Cook, Maria T. Wiekowski, Albert Zlotnik, Theodore J. Standiford, Sergio A. Lira, Shu-Cheng Chen, Borna Mehrad, Jane C. Deng, Galya Vassileva, Denise J. Manfra, Impaired pulmonary host defense in mice lacking expression of the CXC chemokine lungkine. Journal of Immunology. ,vol. 166, pp. 3362- 3368 ,(2001) , 10.4049/JIMMUNOL.166.5.3362
R Bortolussi, T J Marrie, J Cunningham, G Schiffman, Serum antibody and opsonic responses after immunization with pneumococcal vaccine in kidney transplant recipients and controls. Infection and Immunity. ,vol. 34, pp. 20- 25 ,(1981) , 10.1128/IAI.34.1.20-25.1981
William R. Usinger, Alexander H. Lucas, Avidity as a Determinant of the Protective Efficacy of Human Antibodies to Pneumococcal Capsular Polysaccharides Infection and Immunity. ,vol. 67, pp. 2366- 2370 ,(1999) , 10.1128/IAI.67.5.2366-2370.1999
Gestur Vidarsson, Sigurveig T Sigurdardottir, Thorolfur Gudnason, Sveinn Kjartansson, Karl G Kristinsson, Gunnhildur Ingolfsdottir, Steinn Jonsson, Helgi Valdimarsson, Gerald Schiffman, Rachel Schneerson, Ingileif Jonsdottir, None, Isotypes and Opsonophagocytosis of Pneumococcus Type 6B Antibodies Elicited in Infants and Adults by an Experimental Pneumococcus Type 6B-Tetanus Toxoid Vaccine Infection and Immunity. ,vol. 66, pp. 2866- 2870 ,(1998) , 10.1128/IAI.66.6.2866-2870.1998
Eirikur Saeland, Gestur Vidarsson, Jeanette H. W. Leusen, Evert van Garderen, Moon H. Nahm, Henriette Vile-Weekhout, Vanessa Walraven, Annette M. Stemerding, J. Sjef Verbeek, Ger T. Rijkers, Wietse Kuis, Elisabeth A. M. Sanders, Jan G. J. van de Winkel, Central Role of Complement in Passive Protection by Human IgG1 and IgG2 Anti-pneumococcal Antibodies in Mice Journal of Immunology. ,vol. 170, pp. 6158- 6164 ,(2003) , 10.4049/JIMMUNOL.170.12.6158